Mortalin Is a Prognostic Factor of Gastric Cancer With Normal P53 Function

Gastric Cancer - Germany
doi 10.1007/s10120-013-0279-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

EphA4 Is a Prognostic Factor in Gastric Cancer

BMC Clinical Pathology
Forensic MedicinePathologyHistology
2013English

Prognostic Nutritional Index Is an Independent Prognostic Factor for Gastric Cancer Patients With Peritoneal Dissemination

Chinese Journal of Cancer Research
Cancer ResearchOncology
2016English

Prognostic Factor of Gastric Carcinoma-Usefulness for Prognostic Factor and Improvement of Prognosis in Patients With Gastric Cancer.

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
1993English

Expression of High P53 Levels in Colorectal Cancer: A Favourable Prognostic Factor

British Journal of Cancer
Cancer ResearchOncology
1999English

MDM2 Is a Useful Prognostic Biomarker for Resectable Gastric Cancer

Cancer Science
Cancer ResearchMedicineOncology
2013English

Decreased Expression of Eukaryotic Initiation Factor 3f Is an Adverse Prognostic Factor for Stage I–III Gastric Cancer

World Journal of Surgical Oncology
SurgeryOncology
2014English

Overexpression of Hypoxia-Inducible Factor 1 and P53 Is a Marker for an Unfavorable Prognosis in Gastric Cancer

Clinical Cancer Research
Cancer ResearchOncology
2006English

Expression of Ribophorine II Is a Promising Prognostic Factor in Human Gastric Adenocarcinoma

International Journal of Oncology
Cancer ResearchOncology
2016English

COL12A1, a Novel Potential Prognostic Factor and Therapeutic Target in Gastric Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy